Xin Nie

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Computed Tomography

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Thoracic cancer

Asia-Pacific journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Fan Yang, Min Tang, Liang Cui, Jing Bai, Jiangyong Yu, Jiayi Gao, Xin Nie, Xu Li, Xuefeng Xia, Xin Yi, Ping Zhang, Lin Li
Prognostic and predictive impact of molecular tumor burden index in non-small cell lung cancer patients. Thoracic cancer (2023)
Xin Nie, Ping Zhang, Jia-Yin Gao, Gang Cheng, Wei Liu, Lin Li
Sarcopenia as a predictor of initial administration dose of afatinib in patients with advanced non-small cell lung cancer. Thoracic cancer 12 (12) (2021)
Yifan Yang, Liming Wang, Xu Li, Shuai Zhang, Jiangyong Yu, Xin Nie, Wenbo Liu, Xiaonan Wu, Ping Zhang, Yi Li, Ailing Li, Bin Ai
Efficacy and safety of bevacizumab combined with EGFR-TKIs in advanced non-small cell lung cancer: A meta-analysis. Thoracic cancer (2021)
Liming Wang, Yifan Yang, Jiangyong Yu, Shuai Zhang, Xu Li, Xiaonan Wu, Xin Nie, Wenbo Liu, Ping Zhang, Yi Li, Ailing Li, Bin Ai
Efficacy and safety of anti-PD-1/PD-L1 in combination with chemotherapy or not as first-line treatment for advanced non-small cell lung cancer: A systematic review and network meta-analysis. Thoracic cancer 13 (3) (2021)
Xin Nie, Ping Zhang, Gang Cheng, Xiao-Nan Wu, Lin Li
Survival analysis for older patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after progression of first-line gefitinib. Asia-Pacific journal of clinical oncology (2021)
Xin Nie, Lin Li, Juan Huang, Ping Zhang, Hong Shi, Gang Cheng, Yong-Qiang Zhang
From focal pulmonary pure ground-glass opacity nodule detected by low-dose computed tomography into invasive lung adenocarcinoma: A growth pattern analysis in the elderly. Thoracic cancer 9 (11) (2018)
Ping Zhang, Xin Nie, Bing Wang, Lin Li
Combined therapy with osimertinib and afatinib in a lung adenocarcinoma patient with EGFR T790M mutation and multiple HER2 alterations after resistance to icotinib: A case report. Thoracic cancer 9 (12) (2018)